Eckel, B., Karakhanova, S., Bauer, N., Liu, L., & Bazhin, A. V. (2017). A marginal anticancer effect of regorafenib on pancreatic carcinoma cells in vitro, ex vivo, and in vivo. Naunyn-Schmiedeberg's archives of pharmacology, 390(11), . https://doi.org/10.1007/s00210-017-1412-1
Chicago-Zitierstil (17. Ausg.)Eckel, Barbara, Svetlana Karakhanova, Nathalie Bauer, Li Liu, und Alexandr V. Bazhin. "A Marginal Anticancer Effect of Regorafenib on Pancreatic Carcinoma Cells in Vitro, Ex Vivo, and in Vivo." Naunyn-Schmiedeberg's Archives of Pharmacology 390, no. 11 (2017). https://doi.org/10.1007/s00210-017-1412-1.
MLA-Zitierstil (9. Ausg.)Eckel, Barbara, et al. "A Marginal Anticancer Effect of Regorafenib on Pancreatic Carcinoma Cells in Vitro, Ex Vivo, and in Vivo." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 390, no. 11, 2017, https://doi.org/10.1007/s00210-017-1412-1.